# EDGAR Filing Document

**Accession Number:** 0001552968
**File Stem:** 0000950103-25-007539
**Filing Date:** 2025-6
**Character Count:** 16514
**Document Hash:** 7f815fb4acfa24d1005c2e77525616a9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000950103-25-007539.hdr.sgml**: 20250617

**ACCESSION NUMBER**: 0000950103-25-007539

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250617

**FILED AS OF DATE**: 20250617

**DATE AS OF CHANGE**: 20250617

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Lucas Bruce
- **CENTRAL INDEX KEY:** 0001552968

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42707
- **FILM NUMBER:** 251054432

**MAIL ADDRESS:**
- **STREET 1:** 2109 E. PALM AVENUE
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33605
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Slide Insurance Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001886428
- **STANDARD INDUSTRIAL CLASSIFICATION:** FIRE, MARINE & CASUALTY INSURANCE [6331]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 871554861
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 4221 W. BOY SCOUT BLVD.
- **STREET 2:** SUITE 200
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33607
- **BUSINESS PHONE:** (713) 927-4538

**MAIL ADDRESS:**
- **STREET 1:** 4221 W. BOY SCOUT BLVD.
- **STREET 2:** SUITE 200
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33607

## Ex-24

**Exhibit 24**

**POWER OF ATTORNEY**

Know all by these presents, that the undersigned hereby constitutes and appoints Jesse Schalk, as the undersigned's true and lawful attorneys-in-fact to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) obtain and maintain credentials, including any Form ID or amended Form ID, to enable the undersigned, directly or indirectly including through a delegated entity, account administrator or other designated filing agent, to submit and file information and documents via the SEC's Electronic Data Gathering and Retrieval ("EDGAR") system or successor EDGAR Next, including identification codes, verification codes, passwords and password management codes, and any related annual certifications or confirmations, and to act as the undersigned's agent for such purposes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) execute for and on behalf of the undersigned, in the undersigned's capacity as a reporting person pursuant to Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the rules thereunder of Slide Insurance Holdings, Inc. (the "Company"), Forms 3, 4 and 5, including any amendments thereto, in accordance with Section 16(a) of the Exchange Act;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) do and perform any and all acts, directly or indirectly including through a delegated entity, account administrator or other designated filing agent, for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission (the "SEC") and any applicable stock exchange or similar authority;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) prepare, execute and file, or cause to be prepared, executed and filed, on behalf of the undersigned one or more Forms 144, or any amendments thereto, relating to any sales orders (including in connection with the exercise of options to purchase the Company's common stock ("common stock"), orally or electronically, to sell shares of common stock to the public from time to time in accordance with Rule 144 under the Securities Act of 1933, as amended; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of any of such attorneys-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by any of such attorneys-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as any of such attorneys-in-fact may approve in the discretion of any of such attorneys-in-fact.

The undersigned hereby grants to each such attorney-in-fact full power and authority to act separately and to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution, delegation or revocation, hereby ratifying and confirming all that any of such attorneys-in-fact, or the substitute or substitutes or delegee or delegees of any of such attorneys-in-fact, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. This Power of Attorney supersedes all other powers of attorney previously executed by the undersigned in respect of the subject matter described herein.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 5<sup>th</sup> day of June, 2025.

Name: Bruce Lucas

Signature: /s/ Bruce Lucas

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Lucas Bruce<br><sub>(Last) (First) (Middle)</sub><br>C/O SLIDE INSURANCE HOLDINGS, INC.,<br>4221 W. BOY SCOUT BLVD., SUITE 200<br><sub>(Street)</sub><br>TAMPA, FL 33607<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Slide Insurance Holdings, Inc. [ SLDE ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2025-06-17 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director   [X] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_Chief Executive Officer_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 114592<sup>(1)</sup> | D |  |
| Common Stock | 2475000<sup>(1)</sup> | I | By Bruce Lucas Irrevocable Grantor Retained Annuity Trust of 2014 |
| Common Stock | 39875000<sup>(1)</sup> | I | By IIM Holdings II, LLC<sup>(2)</sup> |
| Common Stock | 114592<sup>(1)</sup> | I | By spouse<sup>(3)</sup> |
| Common Stock | 1650000<sup>(1)</sup> | I | By spouse<sup>(4)</sup> |
| Common Stock | 1925000<sup>(1)</sup> | I | By spouse<sup>(5)</sup> |
| Common Stock | 1925000<sup>(1)</sup> | I | By spouse<sup>(6)</sup> |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | <sup>(7)</sup> | <sup>(7)</sup> | Common Stock | 435407<sup>(7)</sup> | <sup>(7)</sup> | D |  |
| Stock Option (right to buy) | <sup>(8)</sup> | 2031-10-07 | Common Stock | 1650000<sup>(9)</sup> | 0.01<sup>(9)</sup> | D |  |
| Stock Option (right to buy) | <sup>(10)</sup> | 2031-10-07 | Common Stock | 1925000<sup>(9)</sup> | 0.01<sup>(9)</sup> | D |  |
| Stock Option (right to buy) | <sup>(11)</sup> | 2032-02-24 | Common Stock | 550000<sup>(9)</sup> | 0.79<sup>(9)</sup> | D |  |
| Stock Option (right to buy) | <sup>(12)</sup> | 2033-07-12 | Common Stock | 2750000<sup>(9)</sup> | 1.38<sup>(9)</sup> | D |  |
| Series A Preferred Stock | <sup>(13)</sup> | <sup>(13)</sup> | Common Stock | 929390<sup>(13)</sup> | <sup>(13)</sup> | D |  |
| Series A Preferred Stock | <sup>(13)</sup> | <sup>(13)</sup> | Common Stock | 100837<sup>(13)</sup> | <sup>(13)</sup> | I | By Bruce Lucas Irrevocable Grantor Retained Annuity Trust of 2014 |
| Restricted Stock Units | <sup>(14)</sup> | <sup>(14)</sup> | Common Stock | 435407<sup>(14)</sup> | <sup>(14)</sup> | I | By spouse<sup>(15)</sup> |
| Stock Option (right to buy) | <sup>(16)</sup> | 2031-10-07 | Common Stock | 330000<sup>(9)</sup> | 0.01<sup>(9)</sup> | I | By spouse<sup>(15)</sup> |
| Stock Option (right to buy) | <sup>(17)</sup> | 2032-02-24 | Common Stock | 275000<sup>(9)</sup> | 0.79<sup>(9)</sup> | I | By spouse<sup>(15)</sup> |
| Stock Option (right to buy) | <sup>(18)</sup> | 2033-07-12 | Common Stock | 550000<sup>(9)</sup> | 1.38<sup>(9)</sup> | I | By spouse<sup>(15)</sup> |

---

### Footnotes:

(1) The number of shares of common stock reported gives effect to the 5.5-to-1 forward stock split, which will occur upon the closing of the issuer's initial public offering.

(2) The securities reported herein are held by IIM Holdings II, LLC, which is an entity controlled by the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

(3) Represent shares of common stock beneficially owned by the reporting person's spouse. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

(4) Represent shares of common stock beneficially owned by the reporting person's spouse through Securus Risk Management LLC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

(5) Represent shares of common stock beneficially owned by the reporting person's spouse through Emma Cloonen Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

(6) Represent shares of common stock beneficially owned by the reporting person's spouse through Ava Cloonen Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

(7) Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. These restricted stock units vest in 24 equal monthly installments commencing on January 1, 2025 and ending on December 31, 2026, subject to the reporting person's continued employment or service through each applicable vesting date. The number of underlying shares of common stock reported gives effect to the 5.5-to-1 forward stock split, which will occur upon the closing of the issuer's initial public offering.

(8) Include 1,512,500 shares underlying the portion of the option that is vested and exercisable. The remaining portion of the option vests in equal monthly installments through September 13, 2025, subject to the reporting person's continued employment or service through each applicable vesting date.

(9) The number of shares of common stock underlying stock options and the applicable exercise price give effect to the 5.5-to-1 forward stock split, which will occur upon the closing of the issuer's initial public offering.

(10) Represent vested portion of the option that vests upon the achievement of the applicable performance goals.

(11) The option vested on December 25, 2023 upon the achievement of the applicable performance goals.

(12) Represent vested portion of the option that vests upon the achievement of the applicable performance goals.

(13) The Series A Preferred Stock is convertible into the issuer's common stock on a one-for-one basis and has no expiration date. All Series A Preferred Stock will be automatically converted into shares of common stock upon the closing of the issuer's initial public offering. The number of underlying shares of common stock reported gives effect to the 5.5-to-1 forward stock split, which will occur upon the closing of the issuer's initial public offering.

(14) Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. These restricted stock units vest in 24 equal monthly installments commencing on January 1, 2025 and ending on December 31, 2026, subject to the recipient's continued employment or service through each applicable vesting date. The number of underlying shares of common stock reported gives effect to the 5.5-to-1 forward stock split, which will occur upon the closing of the issuer's initial public offering.

(15) Represent securities beneficially owned by the reporting person's spouse. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.

(16) The option vests 25% on September 13, 2022 and in equal monthly installments thereafter ending on September 13, 2025, subject to the reporting person's continued employment or service through each applicable vesting date.

(17) The option vested on December 25, 2023 upon the achievement of applicable performance goals.

(18) Represent vested portion of the option that vests upon the achievement of applicable performance goals.

**Signature:** /s/ Jesse Schalk, Attorney-in-Fact for Bruce Lucas  
**Date:** 2025-06-17

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**